Van Khiem Dang

Real-world analysis of afatinib as a first-line treatment for patients with advanced stage non-small-cell lung cancer with uncommon EGFR mutations: a multicenter study in Vietnam

Cam Phuong Pham, L. H. Trinh, Minh Hai Nguyen, 2024, Therapeutic advances in medical oncology.